Dr. Gagandeep Kang | YouTube
Dr Gagandeep Kang | YouTube
Text Size:

New Delhi: Noted scientist Gagandeep Kang has clarified that her resignation from the Translational Health Science and Technology Institute (THSTI), an autonomous institute under the Union science ministry, is driven purely by “personal reasons”.  

Amid the Covid-19 pandemic, Kang held a key role as the executive director at THSTI, which specialises in developing vaccines. 

Speaking to ThePrint Monday, the scientist denied rumours that her resignation stemmed from dissatisfaction with the way the government is expediting the development of indigenous Covid-19 vaccine Covaxin. She also rejected speculation that it was driven by the government’s April decision to disband a vaccine research panel she chaired.

“If I had to resign because of the disbanding of the committee, I would have done it in the same month. I continue to be on several other committees made by the government and I will give my suggestions as and when required,” she said.

Kang added that she is moving to Vellore to be with her husband, a neurosurgeon.

“My husband is there and he is a neurosurgeon where his ward is full of Covid-19 patients. The risk factor due to Covid-19 is very high for him as he has several comorbidity factors including cardiac arrhythmia, diabetes and asthma,” Kang said. “Also, soon he will turn 60.” 

“Due to the lockdown, I have been unable to travel frequently to see him. So, I think it’s a good idea to move back to Vellore. There is no other motive behind my resignation,” she said.

We are deeply grateful to our readers & viewers for their time, trust and subscriptions.

Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.


In Vellore, Kang added, she will join her alma mater Christian Medical College (CMC), where she will start a new project on maternal and child health. 

Also Read: Is COVID-19 a biological weapon and can neem or hot bath prevent it? Fact-checking 24 claims

‘Won’t like to comment on Covaxin’

Last year, Kang became the first Indian woman to be chosen as a Fellow of Royal Society London,  the oldest scientific academy in the world whose fellows are some of the world’s most eminent scientists. As a scientist, she has played a key role in understanding neglected tropical diseases and developing indigenous vaccines for children in India. She was instrumental in developing the country’s first vaccine against RotaVirus. 

Her resignation from THSTI came as a surprise to several Indian scientists and academicians. 

On social media, her resignation was linked to the Indian Council of Medical Research’s (ICMR’s) attempts to expedite the release of an indigenous Covid-19 vaccine — Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited in collaboration with the ICMR. 


While Kang denied her resignation was linked to the vaccine, she refused to comment on Covaxin, which the ICMR is looking to launch by 15 August. “I won’t like to comment on it,” she said.

Also Read: Meet Gagandeep Kang, Shimla scientist who’s helping save lives of thousands of Indian kids


Subscribe to our channels on YouTube & Telegram

News media is in a crisis & only you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.

At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.

Support Our Journalism

1 Comment Share Your Views


  1. Sad to see such eminent scientist and a great person leave THSTI. As a beneficiary of her guidance, I hope she continue to guide science and policy.


Please enter your comment!
Please enter your name here